Ionis Pharmaceuticals(DE:ISI)
€26.03+0.60 (+2.36%)
DE:ISI
Ionis Pharmaceuticals Revenue
€26.03
At close:+0.60 (+2.36%)
Ionis Pharmaceuticals (ISI) Revenue
5 Followers
Ionis Pharmaceuticals Revenue
Ionis Pharmaceuticals had a revenue of 242.72M in the quarter ending Sep 30, 2026, with -9.42%. This bring the company's revenue in the last twelve months to 959.76M, Increased 9.84%. In the fiscal year ending Dec 31, 2025, Ionis Pharmaceuticals had annual revenue of 944.00M with 33.87% growth.
- Revenue (ttm)
- 959.76M
- Revenue Growth
- -5.12%
- P/S Ratio
- 4.48
- Revenue/Employee
- EUR 637,838
- Employees
- 1,480
- Market Cap
- EUR 4.23B
Revenue Chart
Ionis Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 944.00M | 238.86M | 33.87% |
| Dec 31, 2024 | 705.14M | -82.51M | -10.48% |
| Dec 31, 2023 | 787.65M | 200.28M | 34.10% |
| Dec 31, 2022 | 587.37M | -223.09M | -27.53% |
| Dec 31, 2021 | 810.46M | 81.19M | 11.13% |
| Dec 31, 2020 | 729.26M | -393.33M | -35.04% |
| Dec 31, 2019 | 1.12B | 522.92M | 87.20% |
| Dec 31, 2018 | 599.67M | 85.50M | 16.63% |
| Dec 31, 2017 | 514.18M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.